Skip to content
NewsBlazeIN – Lifestyle
Author:
AROA BIOSURGERY
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
September 6, 2026
Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.
July 28, 2026
AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
March 29, 2026